Basic Searches
Searches without any special characters (listed below) will return items that contain the exact value(s) entered in the search field. This means that searching for "ASPIRIN CALCIUM" won't return any items that have "ASPIRIN GLYCINE CALCIUM" because the search term doesn't match exactly.
Boolean Operators
OR - searches with terms separated by " OR " will return items that contain any of the terms in the search.
Example: "ASPIRIN" OR "CALCIUM" will return items that have strings like "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because they contain at least one of the terms in the search.

AND - searches with terms separated by " AND " will return items that contain all the terms in the search.
Example: "ASPIRIN" AND "CALCIUM" won't return items that have strings "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because neither contain both terms, but it will return "ASPIRIN GLYCINE CALCIUM" because it contains both search terms.
version 2.5
Substance Class Protein
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
8PMF8YQX2T
Record Status Validated (UNII)
Record Version
Show Definitional References Hide Definitional References
Download
Name Type Language Details References
DULIGOTUZUMAB
Domain Jurisdiction Naming Organization
drug  
INN   USAN  
INN   USAN  
Official Name
English  
RG7597
Code
English  
DULIGOTUZUMAB [USAN]
Common Name
English  
DULIGOTUZUMAB [INN]
Common Name
English  
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR/EPIDERMAL GROWTH FACTOR RECEPTOR 3) (HUMAN MONOCLONAL MEHD7945A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEHD7945A LIGHT CHAIN, DIMER
Common Name
English  
BISPECIFIC HUMANIZED IGG1 MONOCLONAL ANTIBODY TO EPIDERMAL GROWTH FACTOR RECEPTOR AND HER3
Common Name
English  
MEHD7945A
Code
English  
DULIGOTUMAB
WHO-DD  
Common Name
English  
DULIGOTUMAB [WHO-DD]
Common Name
English  
MEHD-7945A
Code
English  
RG-7597
Code
English  
Classification Tree Code System Code References
NCI_THESAURUS C20401
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
Code System Code Type Description References
ChEMBL
CHEMBL2109405
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
PRIMARY
INN
9646
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
PRIMARY
ChEMBL
CHEMBL3137345
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
PRIMARY
ChEMBL
CHEMBL2109403
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
PRIMARY
CAS
1361184-57-7
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
NO STRUCTURE GIVEN
CAS
1314238-96-4
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
PRIMARY
NCI_THESAURUS
C116628
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
PRIMARY
From To
1_22 1_96
1_148 1_204
1_265 1_325
1_371 1_429
2_22 2_96
2_148 2_204
2_265 2_325
2_371 2_429
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_224 3_214
2_224 4_214
1_230 2_230
1_233 2_233
Glycosylation Link Type Site
N 1_301
N 2_301
Related Record Type Details References
TARGET -> INHIBITOR
none
Mediator Substance Details
none
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
TARGET -> INHIBITOR
none
Mediator Substance Details
none
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
Related Record Type Details References
ACTIVE MOIETY
none
none
Mediator Substance Details
none
Created by admin on Thu Mar 26 03:10:21 EDT 2020 , Edited by admin on Thu Mar 26 03:10:21 EDT 2020
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL 0
Note References
[Validation]WARNING:There are 12 substances with a similar sequence to subunit [1,2]:
(Perform similarity search on subunit [1])
found approximate duplicate (95%) sequence in Subunit [2] of "P188ANX8CK" ("TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [2] of "5384HK7574" ("TRASTUZUMAB DERUXTECAN")
found approximate duplicate (95%) sequence in Subunit [1] of "P188ANX8CK" ("TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [1] of "5384HK7574" ("TRASTUZUMAB DERUXTECAN")
found approximate duplicate (95%) sequence in Subunit [1] of "NO643TK6Y5" ("ZIRCONIUM ZR-89 TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [2] of "NO643TK6Y5" ("ZIRCONIUM ZR-89 TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [1] of "SE2KH7T06F" ("ADO-TRASTUZUMAB EMTANSINE")
found approximate duplicate (95%) sequence in Subunit [2] of "SE2KH7T06F" ("ADO-TRASTUZUMAB EMTANSINE")
found approximate duplicate (95%) sequence in Subunit [1] of "XCR2BZ80N7" ("TRASTUZUMAB DUOCARMAZINE")
found approximate duplicate (95%) sequence in Subunit [2] of "XCR2BZ80N7" ("TRASTUZUMAB DUOCARMAZINE")
found approximate duplicate (96%) sequence in Subunit [2] of "52CMI0WC3Y" ("ATEZOLIZUMAB")
found approximate duplicate (96%) sequence in Subunit [1] of "52CMI0WC3Y" ("ATEZOLIZUMAB")
[Validation]WARNING:There are 14 substances with a similar sequence to subunit [3,4]:
(Perform similarity search on subunit [3])
found approximate duplicate (95%) sequence in Subunit [4] of "JMH6YR91PG" ("VOFATAMAB")
found approximate duplicate (95%) sequence in Subunit [3] of "JMH6YR91PG" ("VOFATAMAB")
found approximate duplicate (95%) sequence in Subunit [3] of "XCR2BZ80N7" ("TRASTUZUMAB DUOCARMAZINE")
found approximate duplicate (95%) sequence in Subunit [4] of "SE2KH7T06F" ("ADO-TRASTUZUMAB EMTANSINE")
found approximate duplicate (95%) sequence in Subunit [3] of "NO643TK6Y5" ("ZIRCONIUM ZR-89 TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [4] of "NO643TK6Y5" ("ZIRCONIUM ZR-89 TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [3] of "P188ANX8CK" ("TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [3] of "5384HK7574" ("TRASTUZUMAB DERUXTECAN")
found approximate duplicate (95%) sequence in Subunit [4] of "5384HK7574" ("TRASTUZUMAB DERUXTECAN")
found approximate duplicate (95%) sequence in Subunit [4] of "P188ANX8CK" ("TRASTUZUMAB")
found approximate duplicate (95%) sequence in Subunit [3] of "SE2KH7T06F" ("ADO-TRASTUZUMAB EMTANSINE")
found approximate duplicate (95%) sequence in Subunit [4] of "XCR2BZ80N7" ("TRASTUZUMAB DUOCARMAZINE")
found approximate duplicate (96%) sequence in Subunit [3] of "52CMI0WC3Y" ("ATEZOLIZUMAB")
found approximate duplicate (96%) sequence in Subunit [4] of "52CMI0WC3Y" ("ATEZOLIZUMAB")
Created Thu Mar 26 03:10:21 EDT 2020
Created By admin
Last Edited Thu Mar 26 03:10:21 EDT 2020
Last Edited By admin
Index Source Text / Citation Source Type Tags Date Accessed File
1 GSRS System-generated Validation messages VALIDATION_MESSAGE Thu Mar 26 03:10:19 EDT 2020
2 USAN COUN 2014 SRS NOMEN
3 USAN COUN 2014 USANCOUN NOMEN PUBLIC_DOMAIN_RELEASE
4 INN List 110 SRS NOMEN
5 SYSTEM
6 inn SRS NOMEN
7 USP DICTIONARY SRS NOMEN
8 STN (SCIFINDER) STN (SCIFINDER) NOMEN
9 SRS import [8PMF8YQX2T] SRS NOMEN Fri Apr 28 15:02:08 EDT 2017
10 INN SRS NOMEN
11 DULIGOTUMAB [WHO-DD] SRS_LOCATOR
12 https://adisinsight.springer.com/drugs/800033001 WEB PAGE
13 SRS CODE IMPORT SRS NOMEN Fri Apr 28 15:02:08 EDT 2017
14 WHO-DD SRS NOMEN
15 DULIGOTUZUMAB [INN] SRS_LOCATOR
16 DULIGOTUZUMAB [USAN] SRS_LOCATOR
17 STN STN (SCIFINDER)
18 STN SRS NOMEN PUBLIC_DOMAIN_RELEASE AUTO_SELECTED
19 STN STN (SCIFINDER)
20 GSRS System-generated Validation messages VALIDATION_MESSAGE Thu Mar 26 03:10:19 EDT 2020